Indication
Latent late syphilis
Late latent syphilis is an asymptomatic stage of systemic infection caused by the spirochete bacterium *Treponema pallidum*, acquired more than one year prior (or more than two years by World Health Organization criteria). Read more about Latent late syphilis
3 drugs 3 manufacturers
Drugs that treat it
Common Latent late syphilis therapies.
EXTENCILLINE (penicillin G benzathine)
BICILLIN L-A (penicillin G benzathine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLate latent syphilis is an asymptomatic stage of systemic infection caused by the spirochete bacterium *Treponema pallidum*, acquired more than one year prior (or more than two years by World Health Organization criteria).
It affects sexually active adolescents and adults, as well as infants through vertical transmission, and is identified solely by persistent treponemal and non-treponemal serologic reactivity in the absence of active clinical signs or symptoms of primary, secondary, or tertiary disease.
Pathophysiologically, the bacteria remain sequestered in host tissues under partial immune control, presenting a lower risk of sexual transmission than early-stage infection but carrying potential long-term risk of progression to tertiary complications or congenital transmission during pregnancy.
- cdc.gov
Late latent syphilis is an asymptomatic stage of systemic infection caused by the spirochete bacterium *Treponema pallidum*, acquired more than one year prior (or more than two years by World Health Organization criteria) Pathophysiologically, the bacteria remain sequestered in host tissues under partial immune control, presenting a lower risk of sexual transmission than early-stage infection but carrying potential long-term risk of progression to tertiary complications or congenital transmissio...
- nih.gov
Late latent syphilis is an asymptomatic stage of systemic infection caused by the spirochete bacterium *Treponema pallidum*, acquired more than one year prior (or more than two years by World Health Organization criteria) Pathophysiologically, the bacteria remain sequestered in host tissues under partial immune control, presenting a lower risk of sexual transmission than early-stage infection but carrying potential long-term risk of progression to tertiary complications or congenital transmissio...
- nih.gov
It affects sexually active adolescents and adults, as well as infants through vertical transmission, and is identified solely by persistent treponemal and non-treponemal serologic reactivity in the absence of active clinical signs or symptoms of primary, secondary, or tertiary disease
- cdc.gov
It affects sexually active adolescents and adults, as well as infants through vertical transmission, and is identified solely by persistent treponemal and non-treponemal serologic reactivity in the absence of active clinical signs or symptoms of primary, secondary, or tertiary disease
- nih.gov
Pathophysiologically, the bacteria remain sequestered in host tissues under partial immune control, presenting a lower risk of sexual transmission than early-stage infection but carrying potential long-term risk of progression to tertiary complications or congenital transmission during pregnancy
Personalize your experience
Follow Latent late syphilis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.